Wall Street brokerages forecast that Israel Chemicals Ltd (NYSE:ICL) will post earnings of $0.10 per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Israel Chemicals’ earnings, with estimates ranging from $0.09 to $0.10. Israel Chemicals posted earnings per share of $0.08 in the same quarter last year, which would suggest a positive year over year growth rate of 25%. The firm is scheduled to issue its next earnings results on Thursday, May 9th.
According to Zacks, analysts expect that Israel Chemicals will report full-year earnings of $0.41 per share for the current fiscal year, with EPS estimates ranging from $0.40 to $0.42. For the next year, analysts anticipate that the business will post earnings of $0.44 per share, with EPS estimates ranging from $0.43 to $0.45. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side analysts that that provide coverage for Israel Chemicals.
Israel Chemicals (NYSE:ICL) last posted its earnings results on Wednesday, February 6th. The basic materials company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.09 by $0.01. Israel Chemicals had a return on equity of 12.33% and a net margin of 22.32%. The firm had revenue of $1.41 billion for the quarter, compared to analyst estimates of $1.37 billion. During the same period last year, the company earned $0.12 earnings per share. Israel Chemicals’s revenue for the quarter was up 3.6% compared to the same quarter last year.
Shares of NYSE:ICL traded down $0.09 during trading on Thursday, reaching $5.25. The stock had a trading volume of 1,655 shares, compared to its average volume of 259,820. Israel Chemicals has a 1-year low of $4.14 and a 1-year high of $6.90. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.39 and a quick ratio of 0.75. The firm has a market capitalization of $6.83 billion, a PE ratio of 14.26, a P/E/G ratio of 1.35 and a beta of 0.86.
Several hedge funds have recently bought and sold shares of ICL. Arete Wealth Advisors LLC acquired a new position in Israel Chemicals during the 4th quarter worth $82,000. Quadrant Capital Group LLC boosted its position in shares of Israel Chemicals by 6,322.8% during the 4th quarter. Quadrant Capital Group LLC now owns 15,479 shares of the basic materials company’s stock worth $87,000 after acquiring an additional 15,238 shares in the last quarter. BlackRock Inc. boosted its position in shares of Israel Chemicals by 5.6% during the 4th quarter. BlackRock Inc. now owns 287,546 shares of the basic materials company’s stock worth $1,628,000 after acquiring an additional 15,307 shares in the last quarter. Credit Suisse AG boosted its position in shares of Israel Chemicals by 2.0% during the 3rd quarter. Credit Suisse AG now owns 922,166 shares of the basic materials company’s stock worth $5,561,000 after acquiring an additional 18,251 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its position in shares of Israel Chemicals by 1.0% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,982,567 shares of the basic materials company’s stock worth $11,955,000 after acquiring an additional 19,052 shares in the last quarter. Hedge funds and other institutional investors own 10.04% of the company’s stock.
About Israel Chemicals
Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash, salt, and Polysulphate; and produces, markets, and sells pure magnesium and magnesium alloys, as well as produces dry carnallite and related by-products, including chlorine and sylvinite.
Further Reading: What are the Different Types of Leveraged Buyouts?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.